Navigation Links
| HOME >> MEDICINE >> TECHNOLOGY |
Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia
Date:12/8/2009
inib Efficacy and Safety in Clinical Trials of Newly Diagnosed Ph+ CML Patients (ENESTnd), is a Phase III randomised, open-label, multicentre trial comparing the efficacy and safety of nilotinib versus imatinib in adult patients with newly diagnosed Ph+ CML in the chronic phase.(1) It is the largest global randomised comparison of two oral therapies ever conducted in newly diagnosed Ph+ CML patients.
ENESTnd is being conducted at 220 global sites, including five sites in the UK, in total 846 patients are enrolled. Patients were randomised to receive nilotinib 400mg twice-daily (n = 281), nilotinib 300mg twice-daily (n = 282) or imatinib 400mg once-daily (n = 283).(1) The primary endpoint was MMR at 12 months; a secondary endpoint was CCyR by 12 months. It is planned that patients are followed up for five years. Patients on the imatinib treatment arm who had suboptimal response or treatment failure will be able to escalate dose and/or switch to nilotinib via a protocol extension.
One of the key effectiveness measures used in the study was called major molecular response (MMR). This is defined as the reduction in levels of the Bcr-Abl protein to less than or equal to 0.1% of the level seen before treatment. MMR is an important measure in CML, as data show that patients who achieve MMR are unlikely to progress to the later stages of the disease.(6) With nilotinib 300mg twice-daily, the rate of MMR at 12 months was twice that of patients receiving imatinib 400mg once-daily (44% vs. 22%, p < 0.0001).(1)
Another effectiveness measure used in the study was called complete cytogenetic response (CCyR). CCyR indicates that no CML cells containing the Ph chromosome can be seen in a sample of bone marrow taken from the patient. 80% of patients achieved CCyR with nilotinib versus 65% with imatinib 400mg once-daily (p < 0.0001).(1) Responses were achieved faster in the nilotinib group than in the imatinib group.(1)
| SOURCE Novartis Oncology Copyright©2009 PR Newswire. All rights reserved |
Related medicine technology :
1. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
2. Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting
3. Emisphere Announces Recruitment of Novartis Phase III Study for Oral Osteoporosis Treatment
4. Video: Novartis Vaccines and PTA Battle Flu: Public Health Vaccination Initiative Urges Families Lets Fight Flu Together!
5. More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies
6. Video: Data on More Than 15 Novartis Oncology Compounds at ASCO Highlight Progress Toward Targeted Therapies for Diverse Tumor Types
7. Juvenile Diabetes Research Foundation, The Genomics Institute of the Novartis Research Foundation Announce Innovative Diabetes Drug Discovery and Development Partnership
8. US FDA Approves Extavia(R) - the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease
9. Results In The New England Journal Of Medicine Confirm Novartis Drug Femara(R) Is Superior To Tamoxifen After Breast Cancer Surgery
10. Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt(TM), an FDA-Approved Oral Therapy for Schizophrenia
11. Novartis Pharmaceuticals Corporation Prevails in Medicaid Pricing Case Before Alabama Supreme Court
Post Your Comments:
(Date:5/23/2013)... y PARÍS, 24 de mayo de 2013 ... un destacado desarrollador y fabricante de herramientas de ... diagnosis y tratamiento de la enfermedad vascular periférica ... ensayo ADVISE ( Ad enosine V asodilator ... valuation) II durante la sesión de ensayo clínico ...
(Date:5/23/2013)... 2013 Haemonetics Corporation (NYSE: HAE ) announced ... EVP-Business Development, will present at The Deutsche Bank 38 th ... MA on May 29, 2013 at 1:30pm Eastern ... The public may access Mr. Lindop,s presentation live via ... Haemonetics (NYSE: HAE ) is a ...
(Date:5/23/2013)... May 23, 2013 MGC Diagnostics Corporation (NASDAQ: ... technology company, today scheduled a conference call to discuss ... year 2013, ended April 30, 2013. The call will ... 2013. The Company will report financial results for the ... close on Thursday, May 30, 2013. ...
Breaking Medicine Technology:Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 2Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 3Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 4Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 5Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 6MGC Diagnostics Corporation to Report Second Quarter Fiscal 2013 Financial Results on Thursday, May 30, 2013 2[0] Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2[0] Haemonetics to Present at The Deutsche Bank 38th Annual dbAccess Health Care Conference[0] MGC Diagnostics Corporation to Report Second Quarter Fiscal 2013 Financial Results on Thursday, May 30, 2013
... 24 Kewaunee Scientific Corporation (Nasdaq: KEQU ) ... July 31, 2010. Sales for the quarter were ... quarter of the prior year. This was primarily the result ... mid-sized laboratory projects and the scheduled timing of shipments in ...
... 24 Women and men with a 10-year cardiovascular ... cholesterol levels but high levels of hsCRP, a protein ... statin therapy, according to new research. (Logo: ... ) The study, published in ...
Cached Medicine Technology:Kewaunee Scientific Reports Sales and Earnings for First Quarter 2Kewaunee Scientific Reports Sales and Earnings for First Quarter 3Kewaunee Scientific Reports Sales and Earnings for First Quarter 4People at 'Intermediate Risk' of Heart Disease With Elevated hsCRP Benefit From Statin Therapy Even if Cholesterol Levels are Normal 2People at 'Intermediate Risk' of Heart Disease With Elevated hsCRP Benefit From Statin Therapy Even if Cholesterol Levels are Normal 3People at 'Intermediate Risk' of Heart Disease With Elevated hsCRP Benefit From Statin Therapy Even if Cholesterol Levels are Normal 4(Date:5/24/2013)... In a coup that surely made other Palm ... the Estetica Institute of the Palm Beaches performed eye surgeries ... morning show, “The Mo & Sally Morning Show.” The DJ’s ... with the results, giving Dr. DeLange and the team at ... Gardens, very valuable free publicity. , Dr. DeLange, the owner ...
(Date:5/24/2013)... FL (PRWEB) May 24, 2013 The producers ... May air dates for Charlotte, North Carolina. It is one ... many Fortune 500 companies. The city is populated with more ... organizations which cover residents in both North and South Carolina. ... all things medically-related can tune into WAXN-TV 64 Eyewitness News ...
(Date:5/24/2013)... 24, 2013 Fit Yummy Mummy, a ... mothers who are trying to get rid of the ... is ideal for women who want to combine exercises ... ’s Stan Stevenson, prompting an investigative review. , ... contains a wide variety of motivational strategies, nutritional plans, ...
(Date:5/24/2013)... GA (PRWEB) May 24, 2013 CBT News.com ... Sales. Gonter joins the web-based retail automotive industry news organization ... , “I’m excited to join a group that’s so ... perfect example of how online video content is on the ... in the motorcycle business and segued into advertising at Cycle ...
(Date:5/24/2013)... Residents of San Diego have a new ... expert, and Certified Russian Kettlebell Instructor, Cody Bramlett has ... San Diego, California. The classes take place Monday through ... Initial sign-ups are available online and by clicking ... for years. The bootcamps being offered in San ...
Breaking Medicine News(10 mins):Health News:Dr. Greg DeLange of the Estetica Institute Recently Performed Eye Surgery on Both Members of Popular Morning Radio Team 2Health News:Health Briefs TV Presents May Air Dates for Charlotte, North Carolina 2Health News:Fit Yummy Mummy: Review Examining Holly Rigsby’s Fitness Program Released 2[0] Dr. Greg DeLange of the Estetica Institute Recently Performed Eye Surgery on Both Members of Popular Morning Radio Team[0] Health Briefs TV Presents May Air Dates for Charlotte, North Carolina[0] Fit Yummy Mummy: Review Examining Holly Rigsby’s Fitness Program Released[0] Tom Gonter to Drive Sales at Retail Automotive News Organization CBT News[0] Kettlebell X Bootcamp Now Offered Six Days A Week in San Diego
... regulation of body weight suggests a potential mechanism underlying ... of two competing hypotheses of weight regulation. In ... General Hospital (MGH) investigators outline a system in which ... animal,s weight tends to gravitate, rather than a single ...
... R. Hill has been appointed,Interim President and CEO of ... to accept a position as president of HealthAmerica,s,Central Pennsylvania ... ) , Hill,s selection ... board of directors. , "The ...
... who allegedly was seriously injured by Medtronic, Inc.,s Infuse(R) ... by Medtronic has sued the company, according to James ... LLC.The firms, along with co-counsel Lieff, Cabraser, Heimann & ... on behalf of Paul and Susan Antonelli, of Amsterdam, ...
... too different from others , , WEDNESDAY, Jan. 14 ... go along with popular opinion in social situations, a ... resonance imaging showed that people whose opinion differed with ... response in the brain,s rostral cingulate zone (RCZ) and ...
... National Cancer Coalition (NCC) and Wyeth Pharmaceuticals (Wyeth) ... assist cancer patients in Latin America with donations ... injection) and Neumega(TM) (oprelvekin). United States Ambassador Michael ... a hand-over event held at the Instituto Nacional ...
... oust reformers, local union officers unopposedOAKLAND, Calif., Jan. ... Rosselli and all 17 other statewide officers were ... chair Debby Schneider. Their victory comes despite a ... to oust reformers in the local union from ...
Cached Medicine News:Health News:New model system may better explain regulation of body weight 2Health News:New model system may better explain regulation of body weight 3Health News:HealthPlus Names Bruce Hill Interim President and CEO 2Health News:Medtronic, Inc. and Medtronic Sofamor Danek USA, Inc. Sued for Product Liability and Promoting the Off-Label Use of Infuse(R) Bone Graft Product, According to Page Perry, LLC 2Health News:NCC and Wyeth Donation to Assist Cancer Patients in Latin America 2Health News:United Healthcare Workers Re-Elect All Statewide Officers 2New model system may better explain regulation of body weightHealthPlus Names Bruce Hill Interim President and CEOMedtronic, Inc. and Medtronic Sofamor Danek USA, Inc. Sued for Product Liability and Promoting the Off-Label Use of Infuse(R) Bone Graft Product, According to Page Perry, LLCBrain May Be Wired for Social ConformityNCC and Wyeth Donation to Assist Cancer Patients in Latin AmericaUnited Healthcare Workers Re-Elect All Statewide Officers
... evaluation of pancreatic -cell function is not only ... of the natural history of diabetes mellitus, but ... guide to the correct choice of treatment. Peripheral ... function because of the large and variable uptake ...
... for the control of glucose metabolism. It ... of Langerhans as the precursor, proinsulin, which is ... are secreted in equimolar amounts into the portal ... of two polypeptide chains, the A-chain and B-chain ...
ENA Screen EIA Auto-Immune Markers 012-MDKES1 Extractable Nuclear Antigens...
Anti-PR3 EIA Auto-Immune Markers 013-PR3-48 Proteinase...
Medicine Products:| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |